Literature DB >> 33502542

An acquired cerebral arteriovenous malformation after brain abscess treatment: case report and a review of the literature.

Hangeul Park1, Eun Jung Koh1,2, Eun Jung Lee1, Jung-Eun Cheon3, Seung-Ki Kim4,5.   

Abstract

A cerebral arteriovenous malformation (AVM) is a congenital and static disease. However, there are increasing reports of acquired AVMs. The pathophysiology of an acquired AVM has not been fully elucidated but the suggested pathophysiology is a combination of genetic abnormalities and inflammatory cytokines caused by previous brain insults. We report a patient who developed an acquired AVM after the treatment for a brain abscess. She underwent Gamma Knife surgery to treat the acquired AVM. It is necessary to understand the characteristics of acquired AVMs and to further research acquired AVMs.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  Acquired arteriovenous malformation; Angiogenesis; Arteriovenous malformation; Brain abscess

Mesh:

Year:  2021        PMID: 33502542     DOI: 10.1007/s00381-021-05050-w

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  3 in total

1.  Symptomatic de novo arteriovenous malformation appearing 17 years after the resection of two other arteriovenous malformations in childhood: case report.

Authors:  Hideaki Akimoto; Kiyohide Komatsu; Yoshihiro Kubota
Journal:  Neurosurgery       Date:  2003-01       Impact factor: 4.654

2.  Brain arteriovenous malformation biology relevant to hemorrhage and implication for therapeutic development.

Authors:  Helen Kim; Ludmila Pawlikowska; Yongmei Chen; Hua Su; Guo-Yuan Yang; William L Young
Journal:  Stroke       Date:  2008-12-08       Impact factor: 7.914

3.  Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia.

Authors:  Sung Ok Park; Mamta Wankhede; Young Jae Lee; Eun-Jung Choi; Naime Fliess; Se-Woon Choe; Seh-Hoon Oh; Glenn Walter; Mohan K Raizada; Brian S Sorg; S Paul Oh
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.